Form 4 for PCVX Vaxcyte, Inc.
Accepted 2026-09-09 17:40:24 ET · period of report 2026-09-04 · accession 0002151661-26-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-09-09 17:40 | 2026-09-04 | PCVX | Jodar Luis | Chief Medical Off | A - Grant | $0.00 | +52.6K | 52.6K | New | $0 |
| D | 2026-09-09 17:40 | 2026-09-04 | PCVX | Jodar Luis | Chief Medical Off | A - Grant | $0.00 | +88.3K | 88.3K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-09-04 | A | A | 52,632 | $0.00 | 52,632 | D | — | — | (F1) Represents the number of shares of Common Stock underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs vest as to 1/4 of the shares subject to the award on September 7, 2027 and 1/8 of the shares every six months thereafter, subject to Reporting Person's continuous service with the Issuer through each such date. |
| 2 | Derivative | Stock Option (right to buy) | 2026-09-04 | A | A | 88,254 | $0.00 | 88,254 | D | $61.16 · — to 2036-09-04 | 88,254 Common Stock | (F2) 1/4 of the shares subject to the option shall vest on August 31, 2027, and 1/48 of the shares shall vest monthly thereafter, subject to Reporting Person's continuous service with the Issuer through each such date. |